Investigating the basis of MAIT cell antigen potency
Project Number5R01AI148407-05
Contact PI/Project LeaderMCCLUSKEY, JAMES
Awardee OrganizationUNIVERSITY OF MELBOURNE
Description
Abstract Text
SUMMARY
Mucosal Associated Invariant T (MAIT) cells comprise up to 10% of human peripheral blood T cells, and are
enriched in the liver, lungs and gastrointestinal mucosa. This indicates that MAIT cells are key players in
immunity. However, their roles in immune protection, and in immunopathology are yet to be fully established.
Nevertheless, MAIT cells are implicated in chronic inflammatory diseases including tuberculosis, peptic
ulceration, periodontal disease and inflammatory bowel disease. Central to the function of MAIT cells is the MAIT
T cell antigen receptor (TCR). Consistent with their innate-like phenotype, MAIT cells express a very restricted
T cell repertoire. Namely, human MAIT cells are characterized by an invariant TCR a-chain (TRAV1-2-TRAJ33)
paired with a limited array of TCR b-chains (TRBV6 or TRBV20). The MAIT TCR is restricted to the monomorphic
Major Histocompatibility Complex class I related protein, MR1. A very high level of conservation of MR1 in
mammals and the restricted MAIT TCR usage strongly indicate an important and evolutionarily conserved
function for the MAIT TCR-MR1 axis in immunity. Based on our previous work and preliminary findings, we aim
to: (i) Investigate novel MAIT cell antigens and their impact on MAIT TCR diversity; (ii) Define the cellular
machinery involved in acquisition and presentation of MR1 antigens; (iii) Investigate the structural basis of MAIT
cell antigen potency and selectivity. Our proposed studies will advance our understanding of MR1 presentation
and subsequent recognition by the MAIT TCR, which is a fundamental precursor for harnessing MAIT cells for
future immunotherapeutics.
Public Health Relevance Statement
NARRATIVE
Mucosal Associated Invariant T (MAIT) cells are an abundant population of T cell in humans. Presently, we know
very little about the function of MAIT cells, their role in protecting humans from microbial infection, or how they
may cause disease (e.g. autoimmunity). This proposal will shed fundamental insight into the nature of the
antigens that can activate or inhibit MAIT cell function.
National Institute of Allergy and Infectious Diseases
CFDA Code
855
DUNS Number
753575117
UEI
P8JJC89CWNK5
Project Start Date
15-June-2020
Project End Date
31-May-2025
Budget Start Date
01-June-2024
Budget End Date
31-May-2025
Project Funding Information for 2024
Total Funding
$539,763
Direct Costs
$519,530
Indirect Costs
$20,233
Year
Funding IC
FY Total Cost by IC
2024
National Institute of Allergy and Infectious Diseases
$539,763
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5R01AI148407-05
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01AI148407-05
Patents
No Patents information available for 5R01AI148407-05
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01AI148407-05
Clinical Studies
No Clinical Studies information available for 5R01AI148407-05
News and More
Related News Releases
No news release information available for 5R01AI148407-05
History
No Historical information available for 5R01AI148407-05
Similar Projects
No Similar Projects information available for 5R01AI148407-05